Destiny Wealth Partners’s Biogen BIIB Stock Holding History

Destiny Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-105	Closed	-$19.3K	–	274
2026 Q1	$19.3K	Buy	+105	New	+$19.3K	﹤0.01%	678
2023 Q2	–	Sell	-889	Closed	-$247K	–	172
2023 Q1	$247K	Sell	889 -127	-13%	-$35.1K	0.05%	167
2022 Q4	$281K	Buy	1,016 +972	+2,209%	+$275K	0.06%	164
2022 Q3	$12K	Hold	44	–	–	﹤0.01%	404
2022 Q2	$9K	Hold	44	–	–	﹤0.01%	438
2022 Q1	$9K	Hold	44	–	–	﹤0.01%	433
2021 Q4	$11K	Sell	44 -40	-48%	-$10.3K	﹤0.01%	431
2021 Q3	$24K	Buy	+84	New	+$27.5K	﹤0.01%	358
2021 Q2	–	Sell	-84	Closed	-$23K	–	215
2021 Q1	$23K	Hold	84	–	–	﹤0.01%	350
2020 Q4	$21K	Buy	+84	New	+$21.7K	﹤0.01%	362

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Destiny Wealth Partners's BIIB Position: Q2 2026 in Review

Destiny Wealth Partners sold out of Biogen (BIIB) in Q2 2026, closing a stake of 105 shares — an estimated $19.3K sold.

Destiny Wealth Partners first reported a position in BIIB in Q4 2020 and held it in 10 quarters. The position peaked at $281K in Q4 2022. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Destiny Wealth Partners reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
Destiny Wealth Partners sold 105 Biogen shares in Q2 2026, an estimated $19.3K.
Destiny Wealth Partners first reported a position in Biogen in Q4 2020 and held it in 10 quarters.
Destiny Wealth Partners's Biogen position peaked at $281K in Q4 2022.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.